These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 15041327

  • 1. Experience with cyclosporine.
    Sandrini S, Setti G, Bossini N, Zubani R, Cassamali S, Maiorca P, Maffeis R, Portolani N, Bonardelli S, Nodari F, Tardanico R, Corbetta G, Cancarini G.
    Transplant Proc; 2004 Mar; 36(2 Suppl):152S-157S. PubMed ID: 15041327
    [Abstract] [Full Text] [Related]

  • 2. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A, Woo KT.
    Clin Transpl; 1999 Mar; ():189-97. PubMed ID: 11038637
    [Abstract] [Full Text] [Related]

  • 3. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N, Rodger RS, McMillan MA, Junor BJ.
    Transplantation; 2007 Mar 15; 83(5):582-7. PubMed ID: 17353778
    [Abstract] [Full Text] [Related]

  • 4. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Mar 15; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 5. Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine.
    Medina-Pestana JO, Felipe CR, Park SI, Machado PG, Garcia R, Spinelli G, Silva LA, Santos CF, Tedesco-Silva H.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):74S-79S. PubMed ID: 15041311
    [Abstract] [Full Text] [Related]

  • 6. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M, Tarantino A, Berardinelli L, Finazzi S, Montagnino G, Rossini G, Scalamogna M, Cesana B, Ponticelli C.
    G Ital Nefrol; 2002 Mar 15; 19(1):49-54. PubMed ID: 12165946
    [Abstract] [Full Text] [Related]

  • 7. Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients.
    Di Paolo S, Teutonico A, Infante B, Stallone G, Schena A, Grandaliano G, Battaglia M, Di Tonno P, Schena FP.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):434S-436S. PubMed ID: 15041381
    [Abstract] [Full Text] [Related]

  • 8. Two decades of experience with cyclosporine in renal transplantation in Helsinki.
    Salmela KT, Kyllönen LE.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):94S-98S. PubMed ID: 15041315
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun 15; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 10. Trends in serum creatinine levels and transplant year.
    Mizutani K, Terasaki P.
    Clin Transpl; 2005 Jun 15; ():355-63. PubMed ID: 17424751
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M, Jardine M, Perkovic V, Cass A, McDonald S, Petrie J, Eris J.
    Transplantation; 2009 Jun 27; 87(12):1877-83. PubMed ID: 19543068
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 13. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.
    Transplant Proc; 2005 Mar 27; 37(2):693-6. PubMed ID: 15848504
    [Abstract] [Full Text] [Related]

  • 14. Graft survival analysis in kidney transplantation: a 12-year experience in a Thai medical center.
    Sirivongs D, Liawnoraset W, Pongskul C, Reungjui S.
    Transplant Proc; 2004 Sep 27; 36(7):2034-7. PubMed ID: 15518736
    [Abstract] [Full Text] [Related]

  • 15. Comparison of survival probabilities for living-unrelated versus cadaveric renal transplant recipients.
    Park YH, Min SK, Lee JN, Lee HH, Jung WK, Lee JS, Lee JH, Lee YD.
    Transplant Proc; 2004 Sep 27; 36(7):2020-2. PubMed ID: 15518731
    [Abstract] [Full Text] [Related]

  • 16. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A, Arlen D, Barrett B, Boucher A, Cardella C, Cockfield SM, Rush D, Paraskevas S, Shapiro J, Shoker A, Yilmaz S, Zaltzman JS, Kiberd B.
    Transplantation; 2008 Oct 15; 86(7):953-60. PubMed ID: 18852662
    [Abstract] [Full Text] [Related]

  • 17. Analysis of cause of death with a functioning graft: a single-center experience.
    Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shimizu T, Shirakawa H, Setoguchi K, Teraoka S, Toma H.
    Transplant Proc; 2004 Sep 15; 36(7):2026-9. PubMed ID: 15518733
    [Abstract] [Full Text] [Related]

  • 18. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 2005 Nov 15; 37(9):3738-42. PubMed ID: 16386523
    [Abstract] [Full Text] [Related]

  • 19. Twenty-five-year survival of living related kidney transplants: thirty-five years' experience.
    Yoshimura N, Akioka K, Ushigome H, Kadotani Y, Ogino S, Wakabayashi Y, Higuchi A, Nobori S, Kaihara S, Okamoto M.
    Transplant Proc; 2005 Mar 15; 37(2):687-9. PubMed ID: 15848502
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul 15; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.